Correction: Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns‑of‑care survey by the SEOR‑GI Group [0.03%]
Sigfredo Elias Romero Zoghbi,Fernando López Campos,Abrahams Ocanto et al.
Sigfredo Elias Romero Zoghbi et al.
Red cell distribution width as a prognostic predictor for colorectal cancer: a meta-analysis [0.03%]
Ruixue Fan,Yijiang Zhang,Junwei Feng
Ruixue Fan
Purpose: Red cell distribution width (RDW) is a simple, low-cost hematological indicator that reflects systemic inflammation and nutritional status. Nevertheless, its prognostic value in colorectal cancer (CRC) remains un...
Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease [0.03%]
Christina Linder-Stragliotto,Panagiotis Tsagkozis,Swapnil Potdar et al.
Christina Linder-Stragliotto et al.
Objective: This study aimed to investigate the feasibility and predictive value in performing ex vivo drug sensitivity testing on bone sarcomas from patients with refractory disease and identify agents with potential ther...
Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis [0.03%]
乳腺炎是乳腺癌的危险因素吗：系统评价和Meta分析研究
Aryane Cristina de Figueiredo Azevedo,Raissa Martins da Silva,Felipe Alves de Paiva et al.
Aryane Cristina de Figueiredo Azevedo et al.
Background: Breast cancer (BC) is the most common cancer among women worldwide, accounting for more than 2.3 million new cases annually. Although chronic inflammation is a well-established risk factor for cancer, the asso...
A novel nomogram incorporating LASSO and Cox regression analyses for predicting survival in early-stage non-small cell lung cancer patients following sublobectomy [0.03%]
结合LASSO和Cox回归分析的早诊非小细胞肺癌亚肺叶切除术后生存预测列线图模型研究
Shuquan Wang,Yunqing Chen,Xiaolin Ma et al.
Shuquan Wang et al.
Background: Sublobectomy remains a key surgical approach for stage I non-small cell lung cancer (NSCLC) patients, yet prognostic tools for postoperative outcomes remain scarce. This study developed a nomogram to predict l...
Immune phenotype and RAS/BRAF status predict outcomes after lung metastasectomy for colorectal cancer [0.03%]
免疫表型和RAS/BRAF状态可预测结直肠癌肺癌转移术后预后
Berta Martin-Cullell,Aida Piedra,Anna Cristina Virgili et al.
Berta Martin-Cullell et al.
Purpose: Colorectal cancer (CRC) presents a marked biological heterogeneity, and the lung is a frequent site of metastatic spread. Although pulmonary metastasectomy can lead to a long-term survival, recurrence rates remai...
Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications [0.03%]
非转移性激素敏感型前列腺癌中雄激素受体途径抑制增强的现有证据及临床意义
Patricia Willisch,Beatriz Vázquez-Barreiro,Ana Plata et al.
Patricia Willisch et al.
Prostate cancer is the most common malignancy in men. Although frequently diagnosed at localized stages, a substantial proportion present high-risk features associated with biochemical recurrence and progression. In non-metastatic hormone-s...
Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review [0.03%]
免疫检查点抑制剂治疗诱导的转移性癌的超进展性疾病：系统评价
JiaJu Xu,ChunXiao Ni,Lidong Qin et al.
JiaJu Xu et al.
The emergence of immune checkpoint inhibitors (ICIs) has ushered in a new era of tumor immunotherapy. These agents function by specifically binding to immune checkpoints, blocking the programmed cell death protein 1 (PD-1)/programmed cell d...
Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances [0.03%]
Ewing肉瘤的靶向和分子治疗：全面回顾临床前和临床研究进展
Christèle Asmar,Raphael Asmar,Guy Awad et al.
Christèle Asmar et al.
Introduction: Ewing sarcoma (EWS) is an aggressive small round blue cell malignancy driven by EWSR1::ETS fusions, with poor survival outcomes in metastatic and relapsed disease. While multimodal chemotherapy remains the c...
Image-based PD-L1 scoring and tumor-infiltrating lymphocytes as predictors for the response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer [0.03%]
基于影像的PD-L1评分和肿瘤浸润淋巴细胞作为非小细胞肺癌新辅助化疗免疫治疗反应预测因素
Jianghua Wu,Wei Sun,Xinying Liu et al.
Jianghua Wu et al.
Purpose: To investigate the predictive performance of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) in pre-treatment biopsies for the response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer (...